Skip to main content

Table 2 Comparison of daily doses of clarithromycin (CAM), rifampicin (RFP), ethambutol (EB), and levofloxacin (LVFX) for pulmonary Mycobacterium avium complex patients between the control and the LVFX group

From: Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease

Drug

Daily dose (mg)

Control group (n = 57)

LVFX group (n = 18)

CAM

400

1

1

600

1

2

800

55

15

RFP

300

11

2

450

46

16

EB

500

29

6

750

26

7

1000

2

2

LVFX

300

-

7

 

375

-

2

 

500

-

9

  1. Values express as number of patients. There was no significant difference for each dosage between both groups
Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us